Cited by 12Herbal Medicine Research StudiesRespiratory viral infections researchPediatric health and respiratory diseases

Analgesic and decongestant efficacy of the combination of aspirin with pseudoephedrine in patients with symptoms of upper respiratory tract infection

Open access
Eccles, Ronald, Voelker, Michael·2014·Clinical Pharmacology in Drug Development

Abstract

The study investigated the efficacy and safety of a combination therapy of 1,000 mg aspirin (ASA) and 60 mg pseudoephedrine (PSE) on the symptoms of pain (combined score for headache and sore throat) and nasal congestion in 833 patients with acute upper respiratory tract viral infection (URTI), over 4 hours after a single dose in the clinic and over 3 days with multiple doses at home. The study demonstrated that over 4 hours in the clinic the combination ASA plus PSE was superior to PSE or placebo for relief of pain symptoms measured subjectively with pain scores, and was superior to ASA or placebo for relief of nasal congestion as measured objectively with rhinomanometry and subjectively with congestion scores. After 3 days of treatment, ASA plus PSE was superior to PSE but not to placebo or ASA for global pain assessments, and ASA plus PSE was superior to ASA and placebo but not to PSE for congestion assessments. No unexpected adverse events occurred and no serious adverse events were attributed to study medicines. This study demonstrates that a combination therapy of ASA plus PSE provides safe and effective relief of both common cold pain related symptoms and nasal congestion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cpdd.39

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Eccles 2014, the sum of nasal congestion differences over three days was significantly higher with the combination than with acetylsalicylic acid (P = 0.016).

    “This was also the case when compared to acetylsalicylic acid (P = 0.016).”

    From Oral antihistamine-decongestant-analgesic combinations for the common cold (2022) · cites this paper as Eccles 2014

    In Results > Efficacy, Table 1 reports that the three-day sum of subjective nasal congestion intensity differences was not significant for the combination versus ASA (P = 0.969). The P = 0.016 result instead applies to total subjective nasal congestion relief over three days. (LLM, conf=0.89)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • In Eccles 2014, the sum of nasal congestion differences over three days was significantly higher with the combination therapy (pseudoephedrine + acetylsalicylic acid) than with placebo (P = 0.048).

    “In Eccles 2014, the sum of nasal congestion differences over three days was significantly higher with the combination therapy (pseudoephedrine + acetylsalicylic acid) than with placebo (P = 0.048).”
  • In Eccles 2014, there was no significant difference between the combination and pseudoephedrine (P = 0.371).

    “When compared to pseudoephedrine there was no significant difference (P = 0.371).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eccles, R., & Voelker, M.
Affiliations
  • Cardiff University (GB)
  • Bayer Consumer Care Morristown NJ USA
Corresponding author
Eccles, Ronald
Venue
Clinical Pharmacology in Drug Development
Publisher
Wiley
Published
2013-08-20
Volume
3
Issue
2
Pages
118-125
ISSN
  • 2160-763X (ISSN-L)
  • 2160-7648
OpenAlex
W1548577492
Cited by
12
References
16
Citations by year
2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2
FWCI
4.73
Type
journal article
Language
en
Open access
Locations
  • Clinical Pharmacology in Drug Development (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
Funders
Bayer HealthCare LLC
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Herbal Medicine Research Studies
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Health Sciences › Health Professions › Emergency Medical Services › Pediatric health and respiratory diseases
Keywords
aspirin, pseudoephedrine, analgesic combination, upper respiratory tract infection, common cold, headache, sore throat, nasal congestion, rhinomanometry, analgesia, drug safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review